Antihypertensive Medication | |||||
---|---|---|---|---|---|
Characteristic | ≥3 Medications | ACE Inhibitor | β-Blocker | Calcium Antagonist | Diuretic |
ACE=angiotensin-converting enzyme; ref=reference group. | |||||
Note: Values are odds ratios adjusted for age, sex, neighborhood socioeconomic status score, and practice-level clustering. | |||||
a Odds for each additional year of age. | |||||
Agea | 1.01 (1.01–1.02) | 1.00 (0.99–1.01) | 1.00 (0.99–1.01) | 1.02 (1.01–1.03) | 1.02 (1.02–1.03) |
Ethnic group | |||||
White | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
Black | 1.60 (1.29–1.99) | 0.72 (0.61–0.83) | 0.84 (0.72–0.97) | 2.83 (2.28–3.51) | 1.27 (1.13–1.43) |
South Asian | 0.66 (0.46–0.96) | 0.63 (0.47–0.84) | 0.99 (0.80–1.21) | 1.33 (0.99–1.77) | 0.84 (0.66–1.06) |
Number of comorbidities | |||||
0 | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
1 | 2.31 (1.87–2.85) | 2.55 (2.19–2.96) | 1.46 (1.21–1.75) | 1.28 (1.11–1.48) | 1.03 (0.93–1.15) |
≥2 | 4.99 (2.45–6.54) | 3.25 (2.59–4.06) | 2.33 (1.89–2.87) | 1.51 (1.24–1.83) | 2.03 (1.72–2.40) |